Peter Mac is an integrated cancer research, treatment and education centre. A place where normal days are extraordinary – as are the people we care for.
Peter Mac research using fruit flies found tumour growth can be switched on or off depending on whether a protein called Chinmo was active - helping reveal that cancer development isn’t just about mutations, but also the environment around them.
More: https://t.co/C26czvki21
A Peter Mac-led clinical trial has shown a potent and precisely targeted form radiotherapy, known as SABR, can cure many patients with inoperable kidney cancers.
Read more: https://t.co/5NjJfCJjDm
Today, on #InternationalNursesDay, we celebrate the extraordinary nurses at Peter Mac and beyond.
Our #nurses provide some of the most specialised cancer care in the world - constantly pushing the boundaries of what exceptional cancer care looks like.
🧠 New from Peter Mac: a web-based program (eReCog) is showing promising results for lymphoma survivors experiencing 'chemo brain' with promising results on processing speed and strong patient engagement.
https://t.co/zqZuSJa0Oj
#CancerResearch#Lymphoma#ChemoBrain
Peter Mac is set to become the first centre to treat a patient under a new PBS-funded CAR T-cell therapy program for multiple myeloma — marking a major step forward for patients with limited options.
More: https://t.co/Jd7pfYMvTR
This ANZAC Day, we remember all who served. We honour our own Sir Peter MacCallum, awarded the Military Cross on the Western Front in WWI, and Matron Nancie Kinsella, who cared for prisoners at Bergen-Belsen in WWII. Lest we forget. #ANZACDay#LestWeForget
A powerful new tool is helping researchers see the invisible — tracking how microbes spread between people with unprecedented precision.
Find out more about this exciting research, out today in @NatureMicrobiol: https://t.co/eULYwmEptp
Huge congrats to Professor @LoiSher who was
awarded the @nhmrc Elizabeth Blackburn Investigator Grant Award - recognising the nation’s top-ranked Investigator Grant application - her work securing $2.9M to advance immunotherapy in breast cancer.
More: https://t.co/Z8YFULlEKB
Huge congratulations to Professor @SarahJ_Dawson on receiving the Nancy Millis Medal.
Her groundbreaking #ctDNA research is transforming how we understand & treat cancer - driving more personalised care and better outcomes.
Read more: https://t.co/deWFGKLMAh
Our immune system has a powerful role fighting cancer — but it’s all about balance.
Research led by @belindaparker's lab shows interferons can boost treatment when just right, but too little or too much can help cancer evade or resist treatment.
More: https://t.co/Ak9rn5ak65
Inspiring to meet @kiranshaw - a true pioneer in biotech, visionary leader, and genuinely authentic in her passion for innovation in global healthcare to improve outcomes for many.
𝗢𝘂𝘁 𝘁𝗼𝗱𝗮𝘆: Researchers at Peter Mac have uncovered a surprising driver behind aggressive lung cancer — embryonic proteins that are normally only active before birth.
Read more: https://t.co/OgdLR3JNN4
#LungCancerResearch#CancerDiscovery#MedicalResearch#LungCancer
As more people survive cancer, attention is turning to life after treatment — including long-term health and fertility.
Researchers at the Peter Mac are studying reproductive health in people receiving immunotherapy for Melanoma.
Learn more: https://t.co/J1BziSwOkM
For Dr Kira Hughes, discovering she was neurodivergent as an adult helped her better understand how she works — & why different ways of thinking can be such a powerful strength in the workplace.
Read Kira's story for @NCWeek: https://t.co/DLEJP17pEy
A clinical trial co-led by Peter Mac has shown a way to reduce the need for invasive biopsies to check for prostate cancer.
It found PSMA PET/CT scanning could halve the number of people requiring a biopsy, without missing any harmful cancers.
More: https://t.co/MXB3n39KC5
Peter Mac is proud to have 6 abstracts presented at @ENETS_ORG 2026. Our multi-centre Australian study on retreatment PRRT won Best Mini-Oral Presentation – Clinical Science, with Peter Mac contributing the highest number of patients.
It was presented by Dr David Chan 👇
Calling all clinicians in #bloodcancer care 🩸
Take part in a national survey evaluating the implementation of AML Clinical Guidelines and Blood Cancer Optimal Care Pathways & help improve awareness, uptake & best-practice care across Australia.
LINK: https://t.co/wbNduUL73g
Three Peter Mac researchers have been awarded @CancerVic Grants in Aid to support innovative projects aimed at developing new and more effective cancer treatments.
Congrats to Prof @JaneOliaro, Dr Alex Lewis and Prof Phil Darcy.
Find out more: https://t.co/4yKTja9FXa